National methicillin-resistant Staphylococcus aureus rates may have more of an influence than local MRSA rates on clinicians' prescription of clindamycin and linezolid to fight the infection, according to an article published in Antimicrobial Resistance and Infection Control.
Read the full article on Becker's ASC Review.
More Articles on Quality:
Study: Reductions in Medicare Payments Slow Mortality Improvements
8 Statistics on Drug Therapy Variability
How Good is Pressure Ulcer Data?